129 related articles for article (PubMed ID: 31704832)
1. Role of Phosphodiesterase2A in Proliferation and Migration of Human Osteosarcoma Cells.
Murata T; Shimizu K; Kurohara K; Tomeoku A; Koizumi G; Arai N
Anticancer Res; 2019 Nov; 39(11):6057-6062. PubMed ID: 31704832
[TBL] [Abstract][Full Text] [Related]
2. Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.
Morita H; Murata T; Shimizu K; Okumura K; Inui M; Tagawa T
Oncol Rep; 2013 Apr; 29(4):1275-84. PubMed ID: 23381931
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.
Hiramoto K; Murata T; Shimizu K; Morita H; Inui M; Manganiello VC; Tagawa T; Arai N
Cell Signal; 2014 Sep; 26(9):1807-17. PubMed ID: 24705027
[TBL] [Abstract][Full Text] [Related]
4. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
Michie AM; Lobban M; Müller T; Harnett MM; Houslay MD
Cell Signal; 1996 Feb; 8(2):97-110. PubMed ID: 8730511
[TBL] [Abstract][Full Text] [Related]
5. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
Manns JM; Brenna KJ; Colman RW; Sheth SB
Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
[TBL] [Abstract][Full Text] [Related]
7. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.
Favot L; Keravis T; Holl V; Le Bec A; Lugnier C
Thromb Haemost; 2003 Aug; 90(2):334-43. PubMed ID: 12888882
[TBL] [Abstract][Full Text] [Related]
8. Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation.
Dickinson NT; Jang EK; Haslam RJ
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):371-7. PubMed ID: 9163326
[TBL] [Abstract][Full Text] [Related]
9. PDE2 activity differs in right and left rat ventricular myocardium and differentially regulates β2 adrenoceptor-mediated effects.
Soler F; Fernández-Belda F; Pérez-Schindler J; Handschin C; Fuente T; Hernandez-Cascales J
Exp Biol Med (Maywood); 2015 Sep; 240(9):1205-13. PubMed ID: 25432985
[TBL] [Abstract][Full Text] [Related]
10. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.
Rivet-Bastide M; Vandecasteele G; Hatem S; Verde I; Bénardeau A; Mercadier JJ; Fischmeister R
J Clin Invest; 1997 Jun; 99(11):2710-8. PubMed ID: 9169501
[TBL] [Abstract][Full Text] [Related]
11. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.
Abusnina A; Keravis T; Zhou Q; Justiniano H; Lobstein A; Lugnier C
Thromb Haemost; 2015 Feb; 113(2):319-28. PubMed ID: 25230992
[TBL] [Abstract][Full Text] [Related]
12. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.
Côté M; Payet MD; Rousseau E; Guillon G; Gallo-Payet N
Endocrinology; 1999 Aug; 140(8):3594-601. PubMed ID: 10433216
[TBL] [Abstract][Full Text] [Related]
13. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
Haynes J; Killilea DW; Peterson PD; Thompson WJ
J Pharmacol Exp Ther; 1996 Feb; 276(2):752-7. PubMed ID: 8632346
[TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.
Vandecasteele G; Verde I; Rücker-Martin C; Donzeau-Gouge P; Fischmeister R
J Physiol; 2001 Jun; 533(Pt 2):329-40. PubMed ID: 11389195
[TBL] [Abstract][Full Text] [Related]
15. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
Méry PF; Pavoine C; Pecker F; Fischmeister R
Mol Pharmacol; 1995 Jul; 48(1):121-30. PubMed ID: 7623766
[TBL] [Abstract][Full Text] [Related]
16. PDE2 is a novel target for attenuating tumor formation in a mouse model of UVB-induced skin carcinogenesis.
Bernard JJ; Lou YR; Peng QY; Li T; Lu YP
PLoS One; 2014; 9(10):e109862. PubMed ID: 25330380
[TBL] [Abstract][Full Text] [Related]
17. Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure.
Zhang Q; Lazar M; Molino B; Rodriguez R; Davidov T; Su J; Tse J; Weiss HR; Scholz PM
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1251-7. PubMed ID: 16100251
[TBL] [Abstract][Full Text] [Related]
18. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
19. A PKG inhibitor increases Ca(2+)-regulated exocytosis in guinea pig antral mucous cells: cAMP accumulation via PDE2A inhibition.
Tanaka S; Tanaka R; Harada S; Kohda Y; Matsumura H; Shimamoto C; Sawabe Y; Marunaka Y; Kuwabara H; Takahashi Y; Ito S; Nakahari T
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(9):G773-80. PubMed ID: 23449671
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
